$CRL News

Charles River Laboratories And Medigen Vaccine Biologics Collaborate On Characterization And Validation Of Virus Seed Bank For MVC's Next-Gen Multivalent Enterovirus Vaccine

If You Invested $100 In Charles River Stock 15 Years Ago, You Would Have This Much Today

5 Insightful Analyst Questions From Charles River Laboratories’s Q2 Earnings Call

Charles River Laboratories (CRL) Q2 2026 Earnings Call Transcript

CRAI Jumps 20% in 3 Months as Demand Broadens Across Key Practices

International Markets and Charles River (CRL): A Deep Dive for Investors

TD Cowen Maintains Buy on Charles River, Raises Price Target to $300

Morgan Stanley Maintains Overweight on Charles River, Raises Price Target to $300

JP Morgan Upgrades Charles River Laboratories International (CRL)

RBC Capital Maintains Outperform on Charles River, Raises Price Target to $282

Charles River Laboratories International Q2 Earnings Call Highlights

Evercore ISI Group Maintains Outperform on Charles River, Raises Price Target to $300

JP Morgan Upgrades Charles River to Overweight, Raises Price Target to $310

Charles River (CRL) Is Up 11.0% After Raising Adjusted EPS Outlook Amid Divestiture-Driven GAAP Losses – Has The Bull Case Changed?

Charles River Laboratories International Inc (CRL) (Q2 2026) Earnings Call Highlights: First ...

Charles River Laboratories International, Inc. (CRL) Q2 2026 Earnings Call Transcript

Charles River Says Biotech Demand Is Back — Bookings Hit Four-Year High

Has Charles River Laboratories International (CRL) Outpaced Other Medical Stocks This Year?

Charles River Blows Out Of A Buy Zone After One Metric Hits A Four-Year High

Charles River (CRL) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates